PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
6548311-4	1984	In 48 patients with a variety of upper gastrointestinal disorders there was a significant correlation between PG I pepsinogens and pentagastrin-stimulated maximal acid output.	Pentagastrin	131-143	biglycan	Homo sapiens	110-114	
43586-3	1979	Pentagastrin evoked a sustained rise in gastric H+ and pepsin secretions, a more delayed and sustained increase in serum PG I in the four subjects with a normal pentagastrin-stimulated maximal gastric secretion, and a fall in serum PG I in the remaining two subjects with a low gastric secretion.	Pentagastrin	0-12	biglycan	Homo sapiens	121-125	
43586-3	1979	Pentagastrin evoked a sustained rise in gastric H+ and pepsin secretions, a more delayed and sustained increase in serum PG I in the four subjects with a normal pentagastrin-stimulated maximal gastric secretion, and a fall in serum PG I in the remaining two subjects with a low gastric secretion.	Pentagastrin	0-12	biglycan	Homo sapiens	232-236	
43586-4	1979	Secretin also elicited a sustained elevation in serum PG I in all four examined, including one who showed a fall in serum PG I during pentagastrin infusion.	Pentagastrin	134-146	biglycan	Homo sapiens	122-126	
43586-6	1979	Thus, the fall in serum PG I during pentagastrin infusion in the two subjects with low gastric secretion may possibly be due to a defective cellular storage of PG I in atrophic gastritis.	Pentagastrin	36-48	biglycan	Homo sapiens	24-28	
43586-6	1979	Thus, the fall in serum PG I during pentagastrin infusion in the two subjects with low gastric secretion may possibly be due to a defective cellular storage of PG I in atrophic gastritis.	Pentagastrin	36-48	biglycan	Homo sapiens	160-164	
6369521-7	1984	According to this study, in consecutive stimulation with insulin and pentagastrin the effect of pentagastrin on serum PG I is inhibited by preceding insulin stimulation in DU patients.	Pentagastrin	69-81	biglycan	Homo sapiens	118-122	
6369521-7	1984	According to this study, in consecutive stimulation with insulin and pentagastrin the effect of pentagastrin on serum PG I is inhibited by preceding insulin stimulation in DU patients.	Pentagastrin	96-108	biglycan	Homo sapiens	118-122	
6369521-9	1984	and then a subsequent pentagastrin stimulation elicits a significant rise in serum PG I.	Pentagastrin	22-34	biglycan	Homo sapiens	83-87